reports on the usefulness of measuring IFP for these tumors, currently, there are no reports on the associa tion between IFP and the prognosis and clinicopatholog ical characteristics of lung cancer, with the exception of studies on human lung cancer xenografts grown in nude mice. 8, 9) Previously, IFP was generally determined via the wick inneedle or micropuncture technique. 10) However, a sim ple method for measuring IFP by using a polyurethane transducertipped catheter was recently developed, 11) and we used this technique to measure the IFP of lung cancer.
The aims of this study were to develop a method to measure IFP for lung cancer showing solid or partsolid appearance on computed tomography (CT) scans and to examine the relationship between IFP and tumor aggres siveness of lung cancer.
Materials and Methods

Eligibility
The study protocol was approved by the Ethical Com mittee of Kumamoto University Hospital in May 2009. Informed consent was obtained from all the patients after discussing the risks and benefits of the study with their surgeons.
Patients
Between September 2009 and January 2013, 501 patients with 514 lung cancers underwent resection at our institute. Of these 514 lesions, 129 showing a pure groundglass appearance on CT scans, 78 showing part solid appearance of which the size of the solid part was <1 cm, and 14 showing pure solid appearance <1 cm were excluded, because it was difficult to ensure tumor localization for IFP measurement during the preliminary experiments (data not shown). In addition, seven lesions with cavities and six lesions treated with preoperative therapy such as chemoradiation, chemotherapy, and radi ation were also excluded. Moreover, 61 lesions could not be measured for IFP because resection was performed while the microtip catheter was under repair or during the absence of the person measuring (T.M.) the IFP, resulting in 219 lesions in 215 patients being measured for IFP. Of these 215 patients, four patients who had two lung cancers were excluded from the analysis. As a result, 211 lesions in 211 patients were included in the analysis ( Table 1) . There were 139 men and 72 women with a mean age of 70 ± 9 years (median: 70 years; range: 39 years-87 years).
Measuring IFP of lung cancer
IFP was measured in the resected lung cancer speci mens. First, the ends of the pulmonary artery and vein of the resected lung cancer, which had been closed via sur gical stapler or ligation, were opened to remove remnant blood. Second, IFP was measured at the center of the tumor, as IFP is reported to be higher in the center than in the peripheral area of the tumor, 12) by using the 1Fr MikroTip sensor catheter (model SPR1000, Millar, Houston, Texas, USA) as described previously. 11) The method of measuring IFP for lung cancer is summarized in Fig. 1 .
Positron Emission Tomography-CT scanning
Sixteen patients did not show accumulation of 18F fluorodeoxyglucose in the lesions; therefore, their maxi mal standard uptake value (SUVmax) was calculated as 0.
Pathological analysis
Hematoxylin and eosin staining and Victoria blue stain ing were performed for all sections to investigate the intratumoral lymphatic and vascular invasion as well as pleural involvement. Pleural involvement was classified as pl0, pl1, pl2, and pl3 (tumors within the subpleural lung parenchyma or superficially invading the pleural connective tissue beneath the elastic layer, tumors invad ing beyond the elastic layer, tumors invading the pleural surface, and tumors invading any component of the pari etal pleura, respectively). The tumors were staged according to the criteria of the 7th edition of Tumor nodemetastasis (TNM) classification. 13) 
Immunohistochemical staining
Immunostaining was performed by the Dako envision system (Dako, Glostrup, Denmark). Antibodies for Ki67 (monoclonal mouse antibody MIB1, 1:50 dilution) and CD34 (monoclonal mouse antibody, NU4A1, 1:50 dilu tion) were purchased from Dako (Denmark) and Nichirei bioscience (Tokyo, Japan), respectively. Sections of 4 mm were cut from the paraffin blocks, and immunostaining was performed with antigenretrieval techniques as pre viously described. 14) Evaluation of immunohistochemical staining The Ki67 labeling index was measured by determin ing the percentage of cells with positive nuclei in >1000 tumor cells in >4 fields. 15) The mean number of tumor cell count was 1112 ± 114. and the following factors were analyzed by using the Spearman rank test: tumor grade, pleural invasion, and clinical/pathological TNM factors. The relationships between IFP and the following factors were analyzed by using the Pearson r test: age, clinical/pathological tumor size, size of the solid part on CT scans, SUVmax, Ki67 index, and MVD. Receiver operating characteristics (ROC) curves were used to determine the cutoff value of IFP for recurrence. Estimated likelihood of events was calculated by using the KaplanMeier method. The logrank test was used to compare differences between curves. Univariate and multivariate analyses were performed with Cox regres sion model. Statistical analysis was performed by using SPSS software (version 18; IBM SPSS Statistics, Chi cago, Illinois, USA). All values in the text and tables are given as mean ± standard deviation. Table 1 shows the patients' characteristics. On high resonance CT scans, lesions showing partsolid features were observed in 63 patients with adenocarcinoma, whereas solid lesions were observed in 148 patients. The longaxis diameter of the pulmonary nodules/masses was selected as the size of the lesions. The mean size of these 211 lesions observed on CT scans was 2.8 ± 1.5 cm (range: 1.0 cm-7.9 cm), and the mean size of the solid part was 2.5 ± 1.5 cm (range: 1.0 cm-7.9 cm). The mean pathological size of the lesions was 2.5 ± 1.4 cm (range: 0.6 cm-8.6 cm). Twenty patients did not undergo posi tron emission tomography (PET), resulting in the rela tionship between IFP and SUVmax being examined in 191 patients. The mean SUVmax was 4.7 ± 4.2 (0-18.7,
Results
CD34 (Microvessel density)
The areas of highest micovessel density (MVD) were used for counting the microvessels. The average numbers of CD34positive capillaries and small venules were care fully counted in 4 highpower fields.
Statistical analysis
The unpaired ttest was used to analyze the associa tions between IFP and sex, appearance on CT scans, his tology (squamous cell carcinoma vs. other histological types), and vessel invasion. The relationship between IFP The metal guide is slowly withdrawn while the sensor is introduced into the center of the tumor, where IFP is measured. In this study, IFP was mea sured by using resected specimens of lung cancer after remnant blood removal. The mean IFP of the 211 lesions was 8.5 ± 6.6 mmHg (range: 0 mmHg -32.7 mmHg), and the mean IFP of the solid lesions was 9.8 ± 6.8 mmHg, which was significantly higher than that of the partsolid lesions (5.5 ± 4.7 mmHg; p <0.001; Table 2 ). IFP correlated with the clinical/ pathological size (p <0.001), but it did not correlate with the size of the solid part observed on CT scans ( Table 2) . The mean SUVmax of lung cancer observed on PETCT scans was 4.7 ± 4.2 ( Table 1) , which showed significant correlation with the IFP (r = 0.475, p <0.001; Table 2 , Fig 2) .
The mean IFPs according to the histological types of lung cancer were as follows: 7.7 ± 6.1mmHg in adeno carcinoma, 10.3 ± 7.5 mmHg in squamous cell carci noma, and 7.3 ± 3.8 mmHg in adenosquamous carcinoma. The mean IFP of squamous cell carcinoma of the lung 
11.6 ± 6.9 Pleural invasion 0.272 <0.001 0 (n = 159) 7.5 ± 5.9 1 (n = 28) 10.5 ± 7.5 2 (n = 7)
10.2 ± 4.3 3 (n = 17)
14.0 ± 8.1 Grade 0.305 <0.001 1 (n = 95) 6.5 ± 4.8 2 (n = 88) 9.7 ± 7.3 3 (n = 26)
11.0 ± 6.9 4 (n = 2) 20. was significantly higher than that of nonsquamous cell carcinoma of lung cancer (7.8 ± 6.1 mmHg) (p = 0.008, Table 2 ). Table 3 shows the correlation between the IFP and pathological TNM stage. Pathological N factor and stage as well as pathological T factor were significantly cor related with the IFP (p <0.001 for all; Table 3 ). Clinical TNM was also significantly correlated with the IFP (data not shown). Moreover, vessel and pleural invasion and tumor grade showed significant correlations with the IFP (p <0.001; Table 2 ). However, while the Ki67 index was significantly correlated with IFP (r = 0.303, p <0.001), the MVD did not ( Table 2) .
The optimal cutoff value of IFP was determined to be 7.4 mmHg using the ROC curve, which was associ ated with the sensitivity and specificity values of 0.74 and 0.61, respectively. Recurrencefree survival (RFS) in the low IFP group (IFP ≤7.4 mmHg) was significantly better than that in the high IFP group (IFP >7.4 mmHg). The 4year RSF of the low and high IFP groups was 84 months and 70 months, respectively (p = 0.001, mean follow up period: 28 ± 11 months; range: 1-54 months; Fig. 3) . Table 4 shows univariate and multivariate analyses of factors influencing RFS. In multivariate analysis, lym phatic vessel invasion was selected as an independent prognositic factor influencing RFS (hazard ratio [HR] 6.5 ± 4.8 T2a (n = 64) 10.6 ± 7.0 T2b (n = 9)
13.9 ± 7.4 T3 (n = 9)
13.3 ± 9.0 T4 (n = 4) 6.1 ± 2.8 N N0 (n = 177) 7.6 ± 6.2 0.356 <0.001 N1 (n = 19)
13.3 ± 6.3 N2 (n = 19)
13.5 ± 6. 11.9 ± 6.4 IIB (n = 6) 12.7 ± 11.5 IIIA (n = 20)
12.8 ± 6.5 IIIB (n = 2) 9.3 ± 2.5 IV (n = 2) 7.9 ± 8.0 SD: standard deviation; TNM: Tumornodemetastasis , p = 0.045) were independent prognostic factors influ encing RFS ( Table 5) .
Discussion
Since the report by Young, et al in 1950, 1) a number of studies on the IFP of solid tumors have been reported. [2] [3] [4] [5] [6] [7] These reports have shown that IFP correlates with the clinicopathological features of various solid tumors includ ing melanoma, lymphoma, cervical cancer, and rectal can cer. Moreover, IFP has been reported to be a prognostic factor for the treatment outcomes of certain solid tumors, [4] [5] [6] [7] such as radiation for cervical cancer [4] [5] [6] and bevacizumab treatment for rectal cancer. 7) However, to date, there have been no reports of IFP concerning lung cancer, with the exception of experiments of human lung cancer xeno grafts in nude mice. 8, 9) To our knowledge, this study is the first report of IFP in clinical cases of lung cancer.
In this report, the IFP was correlated with the tumor size and pathological TNM stage of lung cancer. Similarly, Raut, et al. reported a correlation between the tumor size and the IFP in patients with refractory sarcoma. 16) Moreover, IFP was correlated with both pathological N and T factors in this study, and, Dadiani, et al. had previously reported that high IFP induced fast draining of tumor cells to the lymphatic vessels in mice inoculated with human breast cancer cells. 17) IFP correlated with the tumor size, but it did not correlate with the size of solid part. IFP might not be created only by solid part of the tumor, but might be also created by ground glass part.
In the present study, the cutoff value of IFP for diag nosing recurrence of lung cancer was determined to be 7.4 mmHg by using the ROC curve. Interestingly, the low IFP group (IFP ≤7.4 mm Hg) showed better recurrence free survival than the high IFP group (IFP >7.4 mmHg). Although multivariate analysis did not select IFP as independent prognostic factor, subgroup analysis of the patients with adenocarcinoma selected IFP as indepen dent prognostic factor. These results, as well as those of the previous reports in other types of cancers, [4] [5] [6] [7] support the use of IFP as a candidate novel prognostic factor for lung cancer.
Moreover, IFP was found to correlate with the Ki67 index and SUVmax in this study. Watanabe, et al. reported that the SUV was correlated with the Ki67 in clinical stage IA lung adenocarcinoma; 14) therefore, we speculate that IFP might be able to predict tumor aggressiveness of lung cancer similarly to 18Ffluorodeoxyglucose PET.
Importantly, IFP in this study was measured after resection, not before resection. To puncture the lungs in vivo may cause lethal complications such as air embo lism or pleural dissemination. 18) Even after thoracotomy, puncture of the lung has a possibility to cause such com plications. Before this paper, there had been no reports supporting the benefit of measuring IFP for lung cancer; therefore, in this study, we measured the IFP only after resection.
In this study, the IFP did not show any correlation with the MVD, which differs from the findings of previous reports. Raut, et al. reported that the patients with refrac tory sarcoma demonstrated a decline in IFP and MVD after sorafenib treatment, 15) and Deng, et al. similarly reported that chemotherapy in mice bearing xenografts of A549 cells led to a decline in the IFP and MVD. 19) As mentioned in the Methods section, the IFP in this study was measured in resected specimens after remnant blood removal. There are a number of factors that contribute to the increased IFP in the solid tumor, including blood vessel leakiness, vessel abnormalities, interstitial fibrosis, and contraction of the interstitial matrix. 20) Therefore, the IFP in this study might be weakly influenced by blood flow and vessel factors, compared with the IFPs previ ously reported. 1-9, 16, 19) This report has some limitations. First, the IFP in this study was measured only after resection of lung cancer; the IFP measured during CTguided biopsy or before lung cancer resection might be different from that mea sured in this study. To examine this problem, a novel study in which IFP will be measured before and after lung can cer resection is being planned. Furthermore, this report did not include consecutive patients with lung cancer who underwent surgery at our institute, because of microtip catheter issues and absence of the IFP measurer.
Conclusion
In conclusion, the IFP of lung cancer with solid or partsolid appearance on CT scans measured after resec tion showed correlation with a number of clinicopatho logical factors. Low IFP in the tumors was associated with better recurrencefree survival than high IFP in the tumors; therefore, the IFP of lung tumors might be a novel prognostic factor for lung cancer. 
